6 drug(s) with this reaction
14,317 total reports
Rheumatoid Arthritis has been reported as an adverse reaction across 6 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 14,317 adverse event reports mention rheumatoid arthritis in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with rheumatoid arthritis, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have rheumatoid arthritis listed in their FDA adverse event reports, sorted by report count:
In addition to rheumatoid arthritis, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
6 drug(s) manufactured by Haleon Us Holdings Llc have rheumatoid arthritis listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, and others.
There are a combined 14,317 reports of rheumatoid arthritis across 6 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.